Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/17917
Type
ArticleCopyright
Open access
Sustainable Development Goals
10 Redução das desigualdadesCollections
- IOC - Artigos de Periódicos [12967]
Metadata
Show full item record
GENETIC DIVERSITY AND TRANSMITTED DRUG RESISTANCE OF HIV-1 SUBTYPES IN BLOOD DONORS CANDIDATES IN NORTHERN MOZAMBIQUE
Moçambique
Diversidade genética
Doadores de sangue
Mutação de resistência
Affilliation
Instituto Nacional de Saúde. Maputo, Mozambique.
Instituto Nacional de Saúde. Maputo, Mozambique.
Instituto Nacional de Saúde. Maputo, Mozambique.
Instituto Nacional de Saúde. Maputo, Mozambique.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS and Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS and Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Saúde. Maputo, Mozambique.
Instituto Nacional de Saúde. Maputo, Mozambique.
Instituto Nacional de Saúde. Maputo, Mozambique.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS and Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS and Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Abstract
In order to evaluate the genetic diversity of HIV-1 subtypes and transmitted drug resistance (TDR) mutations in northern Mozambique, we analyzed 120 plasma specimens obtained from drug naive blood donors candidates, who tested positive during routine HIV screening in three blood banks in that region. The genotyping for HIV-1 resistance was performed using Trugene Genotyping SystemTM. HIV-1 genetic subtypes were defined based on entire PR and partial RT gene regions, using REGA HIV-1 Subtyping Tool version 3.0 algorithm and confirmed by phylogenetic inference, using NJ algorithm. The majority of genotyped samples were classified as HIV-1 subtype C (80.0%), followed by subtype A1 (10.5%), subtype D (3.2%) and subtype G (2.1%). The inter-subtype recombinant forms (A1/C, A1/D and C/D) were identified in four participants (4.2%). TDR mutations associated with nucleoside and nonnucleoside reverse transcriptase inhibitors (K219E, G190A, K101E and K103N) were observed in five (5.3%) subjects. Although a large proportion of HIV-1 subtype C was observed, non-C and recombinant forms together correspond to 20% in this study, which is different from what was described in central and southern regions, where subtype C was almost 100%. However, the profile mutations from this study correlate with the ARVs used both for first line schemes and PMTCT in Mozambique. This data reinforces the necessity of continuous surveillance of HIV-1 diversity, TDR and routes of spread, through inner cities of Mozambique to understand better the dynamics of the HIV-1 epidemic and support national public health policies in the country.
Keywords in Portuguese
HIV-1Moçambique
Diversidade genética
Doadores de sangue
Mutação de resistência
Share